Document Detail


Effectiveness and safety of combined antiplatelet and anticoagulant therapy: A critical review of the evidence from randomized controlled trials.
MedLine Citation:
PMID:  21354678     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Antiplatelet and anticoagulant drugs are effective for the prevention of arterial and venous thrombosis but patients continue to experience major cardiovascular events despite their use. Strategies to improve the effectiveness of antithrombotic therapies include selecting the optimal drug and dosing regimen, the use of combinations of antiplatelet and anticoagulant drugs and the development of new more effective drugs to replace existing therapies. Evidence from randomized controlled trials indicates that the combination of aspirin and an anticoagulant is more effective than aspirin alone for the prevention of recurrent cardiovascular events in patients with acute coronary syndrome and is more effective than anticoagulation alone for the prevention of thromboembolic events in patients with mechanical heart valves, but at a cost of increased bleeding. Randomized controlled trials provide no evidence for improved effectiveness of combination therapy compared with antiplatelet therapy alone for the prevention of recurrent cardiovascular events in patients with non-cardioembolic stroke or peripheral artery disease, or compared with anticoagulant therapy alone for the prevention of stroke in patients with atrial fibrillation. Despite lack of evaluation in randomized controlled trials, combination therapy is commonly used in patients with separate indications for antiplatelet therapy (e.g., acute coronary syndrome, recent coronary artery stent) and anticoagulant therapy (e.g., atrial fibrillation with at least one additional risk factor for stroke). Randomized trials are urgently required to evaluate the effectiveness and safety of combining antiplatelet and anticoagulant therapy in these settings.
Authors:
Jeremy S Paikin; Doug S Wright; John W Eikelboom
Related Documents :
16539818 - Therapy for recurrent acute pericarditis: a rheumatological solution?
15674108 - Long-term oral tacrolimus therapy in refractory to infliximab fistulizing crohn's disea...
2661768 - Cyclosporine and azathioprine immunosuppression without maintenance steroids: a prospec...
23223878 - Acromial morphology in patients with calcific tendinitis of the shoulder.
11239528 - Use of a levonorgestrel-releasing intrauterine device in the treatment of rectovaginal ...
8919338 - Rectal mucosal electrosensitivity - what is being tested?
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-2-25
Journal Detail:
Title:  Blood reviews     Volume:  -     ISSN:  1532-1681     ISO Abbreviation:  -     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-2-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8708558     Medline TA:  Blood Rev     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier Ltd. All rights reserved.
Affiliation:
Cardiology Fellow, Hamilton General Hospital, McMaster University, Hamilton, Ontario, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Delays in emergency oral and maxillofacial operations: 5 years later.
Next Document:  Measurements and modeling of reactive nitrogen deposition in southeast Brazil.